New findings from National Taiwan University in the field of osteoporosis described (impact of the requirement for evidence of bone mineral density on the use of anti-osteoporotic drugs, clinical results and patient medical expenses …) : Musculoskeletal diseases and conditions – Osteoporosis

2021 DEC 14 (NewsRx) – By a Journalist-Staff News Editor at Health and Medicine Business Daily – The results of the current study on musculoskeletal diseases and conditions – Osteoporosis have been published. According to information from Taipei, Taiwan, per NewsRx correspondents, the research said: “Since 2011, National health insurance administration (NHIA) published a regulation on the reimbursement of anti-osteoporotic drugs (AOM). This study aimed to assess the impact of this reimbursement regulation on the use of AOMs, clinical outcomes and associated medical expenses of patients with hip fractures.

Financial support for this research includes Ministry of Science and Technology, Taiwan, National Taiwan University Hospital Yun-Lin branch, XinChen Medical Research Foundation, Taiwan.

Our editors got a research citation from National Taiwan University, “Using the National Medicare Research Database (NHIRD), patients with hip fractures between 2006 and 2015 were identified as our study cohort. Patients less than 50 years of age or who had received AOM in the year prior to the incident fracture were excluded. The outcomes of interest were quarterly estimates of the proportion of patients who underwent a bone mineral density (BMD) exam, who were prescribed AOM, as well as those who underwent subsequent visits related to an osteoporotic fracture and associated medical expenses. In particular, age and gender specific estimates have been reported. An interrupted time series study design with a segmented regression model was used to quantitatively explore the impact of changes in reimbursement criteria on the level (immediate) and changes in trend (long term) of these outcomes. Our study included 118,493 patients with an incident hip fracture, with patients over 80 years of age representing the largest proportion. A significantly reduced trend in AOM prescription rates was observed immediately after regulation, except for women aged 65 to 80, while the long-term regimen showed no significant difference. However, the percentage of patients who had a subsequent visit due to an osteoporotic fracture was not statistically different between the pre-regulation and post-regulation periods. It should be noted that political regulation was associated with an upward trend in medical expenses associated with osteoporotic fractures, especially for patients over 80 years of age. The AMO reimbursement regulations reduced the prescription rate for AMOs immediately although the effect was not sustained thereafter.

According to the editors, the research concluded: “However, higher subsequent medical expenses related to osteoporotic fractures have been introduced, especially among the very old population. “

For more information on this research, see: Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporose Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture In Taiwan. International journal of health policy and management, 2020. International journal of health policy and management can be contacted at: Kerman Univ Medical Sciences, Jahad Boulevard, Kerman, 7619813159, Iran.

The editors point out that additional information can be obtained by contacting Fei Yuan Hsiao, National Taiwan University, Pharmacy school, Medical School, Taipei, Taiwan. Additional authors of this research include Chen Yu Wang, Shen Li Jiuan, Shau ​​Huai Fu, Chih-Chien Hung, Rong –Sen Yang, Jou Wei Lin and Ho –Min Chen.

The direct object identifier (DOI) for this additional information is: This DOI is a link to a free or paid online electronic document, and can be your direct source for a journal article and its citation.

(Our reports provide factual information on research and discoveries from around the world.)

About Terry Gongora

Check Also

Ghana: Stick to prescribed medication… GHS advises public

The Ghana Health Service (GHS) kicked off this year’s World Hepatitis Day by appealing to …